methotrexate 5-aminoallyl-2'-deoxyuridine 5'-monophosphate(106449-21-2)
- Name: methotrexate 5-aminoallyl-2'-deoxyuridine 5'-monophosphate
- Synonyms:L-Glutamine,N-[3-[1-(2-deoxy-5-O-phosphono-b-D-erythro-pentofuranosyl)-1,2,3,4-tetrahydro-2,4-dioxo-5-pyrimidinyl]-2-propenyl]-N2-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-(9CI)
- Molecular Formula:C32H38 N11 O12 P
- Molecular Weight:799.684381
- CAS Registry Number:106449-21-2
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.106449-21-2 methotrexate 5-aminoallyl-2'-deoxyuridine 5'-monophosphate
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.106449-21-2 METHOTREXATE 5-AMINOALLYL-2'-DEOXYURIDINE 5'-MONO...
Assay:97% Appearance:Contact us for details Package:According to the requirements of customer Storage:Store in a tightly closed container in a cool and dry place. Transportation:Door to door by Fedex/DHL or by air Application:Research & Development
Min. Order:1Milligram
Supplier:NewCan Biotech Limited [
China (Mainland)]
Other Product
- 1587-41-3/Dichlorodinitromethane
- 16277-16-0/3-formyl-O-methyl-L-tyrosine hydrochloride (1:1)
- 330809-36-4/Siloxanes and Silicones, di-Me, 3-(oxiranylmethoxy)propyl group-terminated, reaction products with N,N-dibutyl-1,3-propanediamine
- 93348-23-3/Fatty acids, olive-oil, oxydi-2,1-ethanediyl esters
- 70265-25-7/2-[5-(benzyloxy)-1H-indol-3-yl]-N-[2-(3,4-dihydroxyphenyl)ethyl]acetamide
- 69178-31-0/Phenanthrene,2-[(1R,2R,5S)-1-ethyl-2,5,6- trimethylheptyl]tetradecahydro-2,4b-dimethyl-,(2S,4aS,4bS,10aS)-
- 143305-95-7/dexapolyspectran
- 95356-74-4/6-(Phenylmethylene)thiazolo(2,3-c)-1,2,4-triazol-5(6H)-one
- 88935-99-3/1-Naphthalenol, 6-(dipropylamino)-5,6,7,8-tetrahydro-2-methyl-, hydrob romide
- 96300-98-0/Vitavax TBZ
- 54697-19-7/bis[(8xi,9xi,14xi,17beta)-3-oxoandrost-4-en-17-yl] butanedioate
- 4353-46-2/1,1'-(1,12-Dodecanediyl)bisguanidine
- 66231-73-0/scaritoxin
- 4289-92-3/5-Oxo-L-proline, compound with L-ornithine (1:1)
- 7500-94-9/2-tert-butyl-6-(propan-2-yl)phenyl propanoate
- 105726-67-8/Neodecanamide, N-methyl-
- 77215-60-2/3-[(dichloroacetyl)amino]alanine
- 13893-97-5/5-methyl-1-phenylhexane-1,3-dione
- 103908-23-2/3,19-Dicarbaatriopeptin-21(rat) (9CI)
- 106449-21-2/methotrexate 5-aminoallyl-2'-deoxyuridine 5'-monophosphate
- 60172-15-8/PYRIDINIUM, 3,3′-(BICYCLO(2.2.2)OCTANE-1,4-DIYLBIS(CARBONYLIMINO-4,1-PHENYL-ENECARBONYLIMINO))BIS-1-PROPYL-, salt with 4-METHYLBENZENESULFONIC ACID (1:2)
- 154663-34-0/N-[5-(4-ethoxy-3,5-dimethoxyphenyl)-1,3,4-thiadiazol-2-yl]-3-(4-methylpiperazin-1-yl)propanamide hydrochloride
- 63879-20-9/2-(diethylamino)ethyl 3-(benzyloxy)-4-methyl-2-nitrobenzoate
- 68038-04-0/Castor oil, polymer with glycerol, maleic anhydride, phthalic anhydride and trimethylolethane
- 27842-38-2/3-(Dimethylamino)-1-hydroxy-1,1-diphenyl-2-propanone
- 3383-27-5/3-chloro-4-(diethylsulfamoyl)phenyl dimethyl phosphate
- 61694-97-1/5-(methylthio)-o-anisic acid
- 71685-56-8/2-[[(11Z,13Z)-11,13-Hexadecadien-1-yl]oxy]tetrahydro-2H-pyran
- 480-72-8/2a,3,4,5-Tetrahydroacenaphthene
- 21015-16-7/N-[α-Methyl-m-(trifluoromethyl)phenethyl]-3-phenylpropiolamide